Review
Published on 27 Jan 2022
Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering
in Hematologic Malignancies
- 18,441 views
- 26 citations
Review
Published on 27 Jan 2022
in Hematologic Malignancies
Original Research
Published on 27 Jan 2022
in Hematologic Malignancies
Review
Published on 26 Jan 2022
in Hematologic Malignancies
Original Research
Published on 24 Jan 2022
in Hematologic Malignancies
Original Research
Published on 24 Jan 2022
in Hematologic Malignancies
Original Research
Published on 24 Jan 2022
in Hematologic Malignancies
Clinical Trial
Published on 21 Jan 2022
in Hematologic Malignancies
Original Research
Published on 21 Jan 2022
in Hematologic Malignancies
Review
Published on 20 Jan 2022
in Hematologic Malignancies
Brief Research Report
Published on 20 Jan 2022
in Hematologic Malignancies
Editorial
Published on 20 Jan 2022
in Hematologic Malignancies
Original Research
Published on 19 Jan 2022
in Hematologic Malignancies
Case Report
Published on 18 Jan 2022
in Hematologic Malignancies
Case Report
Published on 18 Jan 2022
in Hematologic Malignancies
Original Research
Published on 18 Jan 2022
in Hematologic Malignancies
Editorial
Published on 17 Jan 2022
in Hematologic Malignancies
Original Research
Published on 17 Jan 2022
in Hematologic Malignancies
Original Research
Published on 17 Jan 2022
in Hematologic Malignancies
Perspective
Published on 14 Jan 2022
in Hematologic Malignancies
Original Research
Published on 14 Jan 2022
in Hematologic Malignancies
Mini Review
Published on 13 Jan 2022
in Hematologic Malignancies
Original Research
Published on 13 Jan 2022
in Hematologic Malignancies
Review
Published on 13 Jan 2022
in Hematologic Malignancies
Systematic Review
Published on 12 Jan 2022
in Hematologic Malignancies